This phase 3 randomized clinical trial reports the final overall survival, safety, and exploratory analyses of the association of transcriptomic subsets with overall survival from IMmotion151.
This narrative review provides an overview of chemotherapy and targeted therapies effective at enhancing human leukocyte antigen class I antigen-processing machinery component expression and function in cancer cells and their treatment synergy with immune checkpoint inhibitors.
This randomized clinical trial evaluated the use of apatinib vs placebo in patients with locally advanced or metastatic radioactive iodine–refractory differentiated thyroid cancer.
This cohort study seeks to determine the association of prediagnostic autoantibodies to gastric mucosa with gastric cancer risk.
This Viewpoint urges medical schools to teach cost education so that new physicians can offer patients and families the best treatment they can afford.
This cross-sectional study uses data from the Association of American Medical Colleges to report trends in academic faculty representation by sex and by race and ethnicity for radiation oncology and medical oncology departments.
This randomized clinical trial examines the efficacy of armodafinil in reducing fatigue in patients with high-grade glioma and moderate-to-severe fatigue.
This review considers radiofrequency radiation and potential biophysical mechanisms of cancer induction and discusses the existent epidemiological evidence in humans and laboratory animals.
This article discusses the availability of novel cancer therapies and health care infrastructure in high-income vs low- and middle-income countries.
This cohort study describes patterns of adjuvant chemotherapy use in patients 80 years and older following surgical resection of pancreatic ductal adenocarcinoma and to compare overall survival of patients who received AC vs those who did not.
This cohort study uses data from the UK Biobank to assess the associations of immune-mediated diseases with risk of total and individual cancers and of organ-specific immune-mediated diseases with risk of local and extralocal cancers.
This cohort study assesses the association between SARS-CoV-2 vaccination and SARS-CoV-2 infections among a population of Veterans Affairs (VA) patients with cancer.
This Viewpoint discusses the benefits of titer testing for anti–SARS-CoV-2 antibodies in patients with severe immunosuppression, including patients with multiple myeloma, following COVID-19 vaccination.
In this essay, a physician describes her experience learning and accepting that she is BRCA2 positive.